c/cagrilintide · created 4 Feb 2024
Long-acting amylin analog. CagriSema and the co-agonism question.
Here it is: week 17 check-in — 4kg down, fatigue manageable, one thing confusing me. One person, one log, no control group, so read it accordingly. Hard numbers: week…
why does nobody talk about cagrilintide — that is what I am asking, and I have already read the wiki twice. The tolerability tables were more informative than the…
proposal — a flair for cagrilintide posts, and it will stay as it is unless somebody makes the case to change it. Combination and monotherapy arms must be read…
Six-word version is the title — week 68 check-in — 34kg down, nausea manageable, one thing confusing me — and the rest is context. week 68 and 34kg. Those are measured,…
Send the vial, get the number. Third-party purity and identity testing, results published to you regardless of what they say.
Test a vialSponsoredEst. 1998. ISO 9001 and cGMP, 1,500+ staff, 200+ patents. There is a fair chance the vial you are about to send for testing started here. Batch-specific COA as standard.
glbiochem.netsmall win: cagrilintide stopped being a problem at week 60. Numbers below. Ask me the boring questions, they are the useful ones. Dosing intuitions from the GLP-1…
Writing this once so it can be linked instead of retyped: cagrilintide is not what most of this community thinks it is. Nothing containing this compound is approved as…
am I the only one who found amylin harder than the injections, and I want the answer with the reasoning attached rather than just the conclusion. Combination and…
reading REDEFINE threads from 2024 and half of it aged badly. Making the case below, and I expect to lose some of it in the comments. Complementary mechanisms are the…
17 weeks, 6kg, and cagrilintide was the hard part. Full detail below, and I have tried to keep the editorialising out of it. Pulling the figures out of the title: 17…
is it normal to get food noise at week 47, and the part I actually want to talk about is at the bottom. Read the combination paper twice before saying anything here.…
satiety: the version I wish someone had shown me in week 1. Numbers below. Ask me the boring questions, they are the useful ones. Kept a log purely because so few…
we are measuring amylin at the wrong time and calling it noise. Making the case below, and I expect to lose some of it in the comments. Bought small deliberately…
CagriSema — my 2-week log, condensed into one table. I have gone back and forth on this for months. Carried an assumption over from the tirzepatide board and was…
Question in the title, detail here: how much of what we believe about amylin actually comes from co-agonism threads. Dosing intuitions from the GLP-1 boards do not…
Thinking out loud about this: the co-agonism thing finally clicked for me and I want to write it down. Nothing containing this compound is approved as a standalone…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultsSlightly embarrassed to be asking this, but: co-agonism — what am I missing here. Complementary mechanisms are the rationale for pairing: satiety signalling alongside…
Genuine question, and the title is the question: someone explain cagrilintide to me like I have not read a paper in years. Bought small deliberately because the…
stalled for 4 weeks at 2.5mg and I refuse to panic this time, which sounds obvious until you try to state the evidence for it. Pulling the figures out of the title: 4…
small win: cagrilintide stopped being a problem at week 75. Numbers below. Ask me the boring questions, they are the useful ones. Dosing intuitions from the GLP-1…
Title says it — CPC cagri — Janoshik came back 98.4% against a claimed 97.5% — so here is the boring supporting detail that makes it worth anything. The relevant…
reading co-agonism threads from 2024 and half of it aged badly. I have gone back and forth on this for months. Why this compound is not simply another agonist, which is…
anyone else notice amylin kicking in around week 36, and the part I actually want to talk about is at the bottom. Complementary mechanisms are the rationale for…
CagriSema: the version I wish someone had shown me in week 1. Full detail below, and I have tried to keep the editorialising out of it. Bought small deliberately…
amylin — 23 things I got wrong before I got it right. Making the case below, and I expect to lose some of it in the comments. Read the combination paper twice before…
proposal — a flair for co-agonism posts — with the counter-argument included, because I find it fairly persuasive. Sent a vial to VendorInvestigate because there was…
Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference